mitomycin has been researched along with Keratoconjunctivitis in 4 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Keratoconjunctivitis: Simultaneous inflammation of the cornea and conjunctiva.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To clinically evaluate topical mitomycin chemotherapy in patients with diffuse, multifocal, or recurrent primary acquired melanosis with atypia and/or conjunctival malignant melanoma and to histopathologically study ocular tissue samples obtained before and after treatment." | 9.09 | Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations. ( Demirci, H; Finger, PT; McCormick, SA, 2000) |
| "04% mitomycin-C, either postoperatively for 2 weeks or intraoperatively as a single dose, as an adjunct in the surgical treatment of primary pterygium was evaluated." | 9.08 | Intraoperative and postoperative use of mitomycin-C in the treatment of primary pterygium. ( Calişkan, S; Irkeç, M; Orhan, M, 1996) |
| "To clinically evaluate topical mitomycin chemotherapy in patients with diffuse, multifocal, or recurrent primary acquired melanosis with atypia and/or conjunctival malignant melanoma and to histopathologically study ocular tissue samples obtained before and after treatment." | 5.09 | Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations. ( Demirci, H; Finger, PT; McCormick, SA, 2000) |
| "04% mitomycin-C, either postoperatively for 2 weeks or intraoperatively as a single dose, as an adjunct in the surgical treatment of primary pterygium was evaluated." | 5.08 | Intraoperative and postoperative use of mitomycin-C in the treatment of primary pterygium. ( Calişkan, S; Irkeç, M; Orhan, M, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oliveira, RF | 1 |
| Ferreira, GA | 1 |
| Ghanem, VC | 1 |
| Corrêa-Dantas, PE | 1 |
| Ghanem, RC | 1 |
| Gericke, A | 1 |
| Pitz, S | 1 |
| Strempel, I | 1 |
| Sekundo, W | 1 |
| Calişkan, S | 1 |
| Orhan, M | 1 |
| Irkeç, M | 1 |
| Demirci, H | 1 |
| McCormick, SA | 1 |
| Finger, PT | 1 |
2 trials available for mitomycin and Keratoconjunctivitis
| Article | Year |
|---|---|
Intraoperative and postoperative use of mitomycin-C in the treatment of primary pterygium.
Topics: Administration, Topical; Chemotherapy, Adjuvant; Follow-Up Studies; Humans; Intraoperative Period; K | 1996 |
Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations.
Topics: Administration, Topical; Adult; Aged; Antibiotics, Antineoplastic; Atrophy; Chemotherapy, Adjuvant; | 2000 |
2 other studies available for mitomycin and Keratoconjunctivitis
| Article | Year |
|---|---|
Transepithelial Surface Ablation With Mitomycin C for the Treatment of Chronic Central Corneal Scars Following Adenoviral Keratoconjunctivitis.
Topics: Ablation Techniques; Adenovirus Infections, Human; Adult; Cornea; Corneal Injuries; Corneal Topograp | 2020 |
[Bilateral ocular surface squamous neoplasia and neurodermatitis. Two cases with different courses].
Topics: Adult; Antibiotics, Antineoplastic; Biological Dressings; Carcinoma, Squamous Cell; Chemotherapy, Ad | 2008 |